DaVita, Fresenius To Participate In Rockwell’s Iron-Replacement Studies
With the participation of the two largest US dialysis companies, Rockwell Medical will conduct two pivotal Phase 3 trials for Soluble Ferric Pyrophosphate as a continuous iron-replacement therapeutic.
Read More